Embla Medical hf
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and … Read more
Embla Medical hf (EMBLA) - Total Assets
Latest total assets as of December 2025: Dkr1.74 Billion DKK
Based on the latest financial reports, Embla Medical hf (EMBLA) holds total assets worth Dkr1.74 Billion DKK as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Embla Medical hf - Total Assets Trend (2020–2025)
This chart illustrates how Embla Medical hf’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Embla Medical hf - Asset Composition Analysis
Current Asset Composition (December 2025)
Embla Medical hf's total assets of Dkr1.74 Billion consist of 26.2% current assets and 73.8% non-current assets.
| Asset Category | Amount (DKK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 5.9% |
| Accounts Receivable | Dkr153.21 Million | 8.8% |
| Inventory | Dkr165.26 Million | 9.5% |
| Property, Plant & Equipment | Dkr0.00 | 0.0% |
| Intangible Assets | Dkr106.68 Million | 6.1% |
| Goodwill | Dkr833.74 Million | 47.9% |
Asset Composition Trend (2020–2025)
This chart illustrates how Embla Medical hf's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Embla Medical hf's current assets represent 26.2% of total assets in 2025, a decrease from 26.9% in 2020.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, down from 8.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 53.0% of total assets, a decrease from 54.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 47.9% of total assets.
Embla Medical hf Competitors by Total Assets
Key competitors of Embla Medical hf based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Embla Medical hf - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Embla Medical hf generates 0.55x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Embla Medical hf generates $ 4.96 in net profit.
Embla Medical hf - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.48 | 1.90 | 2.19 |
| Quick Ratio | 0.94 | 1.21 | 1.50 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Dkr148.10 Million | Dkr 187.67 Million | Dkr 171.04 Million |
Embla Medical hf - Advanced Valuation Insights
This section examines the relationship between Embla Medical hf's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.31 |
| Latest Market Cap to Assets Ratio | 0.36 |
| Asset Growth Rate (YoY) | 13.2% |
| Total Assets | Dkr1.74 Billion |
| Market Capitalization | $621.39 Million USD |
Valuation Analysis
Below Book Valuation: The market values Embla Medical hf's assets below their book value (0.36 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Embla Medical hf's assets grew by 13.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Embla Medical hf (2020–2025)
The table below shows the annual total assets of Embla Medical hf from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Dkr1.74 Billion | +13.23% |
| 2024-12-31 | Dkr1.54 Billion | +11.06% |
| 2023-12-31 | Dkr1.39 Billion | +4.55% |
| 2022-12-31 | Dkr1.33 Billion | +6.29% |
| 2021-12-31 | Dkr1.25 Billion | +2.68% |
| 2020-12-31 | Dkr1.21 Billion | -- |